In lung cancer, previous studies have explored the relationships between MUC5B expression and clinicopathological characteristics, which found that overexpression of MUC5B was associated with early post-operative metastasis and poor overall survival (OS) in patients with lung adenocarcinoma19–22. The gene discussed is MUC5B; the disease is lung cancer.